Skip to content
JNNP Podcast cover art

All episodes

JNNP Podcast, 181 episodes. Page 2 of 2.

#
Title
101

BNPA 2014: Oxytocin and social cognition

102

BNPA 2014: Schizophrenia and cognition

103

Advances in epilepsy surgery

104

Brain atrophy and disability progression in multiple sclerosis patients

105

BNPA 2014: Joint hypermobilty and autonomic hyperactivity

106

BNPA 2014: Post-Ictal psychosis

107

BNPA 2014: TREM2 variants and risk of dementia

108

Neurosurgical procedures for psychiatric illness

109

Can stress trigger Parkinson’s? And new criteria for frontotemporal dementia syndromes.

110

HIV and multiple sclerosis: beginning to unravel a mystery

111

BNPA 2014: Neuropsychiatry of social knowledge and moral motivation

112

DBS in essential tremor, and genetic counselling for ALS

113

Mortality and morbidity 15 years after hospital admission with mild head injury

114

Informed decision making in MS, and the striatum in neurodegeneration

115

BNPA special: Autoimmune encephalitis

116

BNPA special: The prospects of a vaccine for Alzheimer’s disease

117

An unusual variant of Guillain–Barré syndrome, and dopamine dysregulation syndrome

118

BNPA special: Impulse control disorder in Parkinson’s

119

Diagnosing and treating functional symptoms

120

Solving the case, making the diagnosis: Neurology and detective writing

121

Radiation for brain metastases, and the genetics of ischaemic stroke

122

Education special: Headache

123

Aggressive MS, and disappointment following deep brain stimulation for Parkinson’s

124

Vitamin D, sunlight, and MS

125

Education special: Neurogenetics update

126

Diagnosing and treating neuromyelitis optica

127

Diagnosing the dementias

128

Anti-GQ1b antibody syndrome, and ALS and language deficits

129

Striatal cell transplants for Huntington’s disease: where are we now?

130

Education special: MS update

131

Education special: Peripheral nerve disease update

132

Stem cells in neurology, and enlarged perivascular spaces and intracerebral haemorrhage

133

Parkinson’s disease subtypes: lost in translation?

134

The latest on stroke

135

Dopamine agonist withdrawal syndrome

136

BNPA 2013: The impact of epilepsy on cognitive function

137

BNPA 2013: Psychedelic drugs, magical thinking and psychosis

138

BNPA 2013: Decoding consciousness

139

BNPA 2013: Epilepsy, depression and anxiety disorders

140

BNPA 2013: Brain networks in human epilepsy

141

BNPA 2013: Cellular mechanisms of epilepsy

142

BNPA 2013: Autoimmunity and neuropsychiatry

143

BNPA 2013: Deep brain stimulation for mental illness

144

BNPA 2013: The neural correlates of Freudian “repression” in conversion disorder

145

BNPA 2013: Effects of early childhood posterior fossa tumours on IQ

146

BNPA 2013: Epilepsy and affective disorders, the role of the subgenual prefrontal cortex

147

BNPA 2013: Stress and war, and the limits of neuropsychiatry

148

BNPA 2013: Childhood stress and risk for later mental disorder

149

BNPA 2013: Inflammation and mental illness

150

BNPA 2013: Posttraumatic stress disorder and the brain

151

BNPA 2013: Equipped to survive, how comprehensive response to threat enables optimal behaviour

152

Discovering Emery-Dreifuss muscular dystrophy, and flavour identification in FTLD

153

The future of epilepsy research, assessing hemianopia, measuring sensory nerve action potentials

154

The Scheltens scale, disability after head injury, and cannabis for multiple sclerosis

155

Early days of the Queen Square brain bank; rating dopaminergic replacement therapy response

156

Oliver Sacks’s functional paralysis; progressive multifocal leukoencephalopathy

157

Recovery after stroke; malingering after concussion

158

The future of glioblastoma therapy

159

Neurological symptoms from autoimmune syndromes; movement disorders and OCD; counting strokes

160

Idiopathic intracranial hypertension; discovering the neurological effects of critical illness

161

Diagnostic criteria for CBS; tractography in ALS fifty years ago; better tests for bvFTD

162

Surrogate outcomes; CAA and IH; Angela Vincent looks back

163

Cerebral amyloid angiopathy; lifestyle and mortality after stroke; motor output patterns

164

The early days of chronic fatigue syndrome research; Clues to functional weakness mechanism

165

Diagnosing delirium

166

Diagnosing conversion disorder; exercise to prevent falls in Parkinson’s patients

167

The natural history of Parkinson’s; the latest on MS and latitude

168

Athleticism and ALS; understanding peripherally induced movement disorders

169

Thrombolysis for elderly stroke patients; disability with organically-unexplained symptoms

170

Finger length ratio and ALS; psychotherapy for dizziness

171

Frontotemporal dementia reviewed; temporal orientation and dementia

172

Dementia and word knowledge; DBS for Parkinson’s

173

Genes, vitamin D and MS; hysteria and hypnosis

174

Eye movements in motor neurone disease; work and multiple sclerosis

175

October 2010

176

Predicting adjustment to an ALS diagnosis

177

Microbleeds and abuse in dementia

178

Migrane co-morbidities

179

The SCAN rule

180

Epilepsy and driving; Self awareness in dementia

181

Pregnancy and MS